MedTrace Logo

Left Atrial Thrombus on Transesophageal Echocardiography

NCT03591627 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-11-05

No results posted yet for this study

Summary

The aim of the study is to assess the prevalence of left atrial thrombus in patients with atrial fibrillation (AF) or atrial flutter (AFI), in whom transesophageal echocardiography is performed before AF/AFl cardioversion or ablation.

Conditions

  • Atrial Fibrillation
  • Atrial Flutter
  • Transesophageal Echocardiography
  • Ablation
  • Cardioversion
  • Thrombus; Embolism

Interventions

DIAGNOSTIC_TEST

Transesophageal echocardiography

Transesophageal echocardiography will be used to exclude the presence of an LA thrombus before AF/AFI ablation or cardioversion.

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03591627 on ClinicalTrials.gov